From the publishers of JADPRO
Bone Protection
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Test your knowledge on the use of bone-modifying agents in patients with prostate cancer
Last Updated: Thursday, July 28, 2022
Dosing and Duration of BMAs in an Older Patient With Prostate Cancer
Loading...
Advertisement
News & Literature Highlights
Cells
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
Current Osteoporosis Reports
Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic Therapies
JAMA Network Open
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy
Journal of the National Comprehensive Cancer Network
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Annals of Pharmacotherapy
Impact of Extended-Interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Non–Small-Cell Lung Cancer and Small-Cell Lung Cancer Patients With Bone Metastases
JAMA Open Network
Description of Major Osteoporotic Fractures in Women With Invasive Breast Cancer Who Received Endocrine Therapy
JAMA Open Network
Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
Journal of Bone Oncology
Bone Metastases From Urothelial Carcinoma. The Dark Side of the Moon
Metabolism
Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials
Journal of Clinical Oncology
Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: ASCO-OH (CCO) guideline update
Advertisement
Case Studies
Postmenopausal Patient With ER+ Early-Stage Breast Cancer: Bone Protection and Shared Decision-Making
Bone Protection During Chemotherapy in Metastatic Lung Cancer
Dosing and Duration of BMAs in an Older Patient With Prostate Cancer
Take our brief survey to share how your practice manages bone health
Take Survey Now
Fast Facts
Fast Facts #3: Prostate Cancer and Bone Metastases
Advertisement
Quizzes
Test your knowledge on optimizing bone protection in patients with breast cancer
Test your knowledge on diagnosis of osteolytic bone lesions
Test your knowledge on prevention of skeletal-related events